Self-Reinforced Cancer Targeting (SRCT) Depending on Reciprocally Enhancing Feedback between Targeting and Therapy

Area of Science:

• Biomedical Engineering
• Oncology
• Nanotechnology

Background:

• Conventional cancer targeting faces limitations due to poor efficiency.
• Reforming targeting strategies is crucial for effective cancer therapy.

Purpose of the Study:

• To introduce and validate the concept of self-reinforced cancer targeting (SRCT).
• To develop a GRP78-targeting nanomedicine for enhanced chemotherapy delivery and efficacy.

Main Methods:

• Designed a GRP78-targeting nanovehicle for chemotherapy delivery.
• Investigated the upregulation of GRP78 expression on cancer cells in response to treatment.
• Evaluated targeting efficacy and therapeutic performance in vitro and in vivo.

Main Results:

• Chemotherapeutic drugs upregulated GRP78 on cancer cells with minimal effect on normal cells.
• GRP78-targeting nanomedicine demonstrated enhanced targeting and therapeutic performance.
• SRCT approach showed superior antitumor activity compared to non-targeting methods.

Conclusions:

• SRCT leverages treatment-induced target upregulation for improved cancer targeting.
• The GRP78-targeting nanomedicine shows significant potential for advancing cancer therapy.
• SRCT offers a promising strategy by creating a positive feedback loop between targeting and therapy.